Latest Naproxen News

Horizon Pharma plc Announces Pricing of Secondary Offering of Ordinary ... ... inflammation and orphan diseases. Horizon's U.S. marketed products...


Horizon Pharma plc Announces Pricing of Secondary Offering of Ordinary
… inflammation and orphan diseases. Horizon's U.S. marketed products are ACTIMMUNE(R) (interferon gamma-1b), DUEXIS(R) (ibuprofen/famotidine), RAYOS(R) (prednisone) delayed-release tablets and VIMOVO(R) (naproxen/esomeprazole magnesium).
Read more on MarketWatch

Leave a Reply